Rebecca C. Arend
ORCID: 0000-0003-2108-3426
· 7 papers in corpus
review
2026
Background/Objectives: Depot medroxyprogesterone acetate (dMPA) is a synthetic progestin commonly used for contraception. Recent studies have reported an increased association between dMPA exposure and diagnosis of cerebral meningioma. The …
nonrandomized-trial
2025
PURPOSE: To evaluate exemestane, an aromatase inhibitor, as a preventive intervention for endometrial cancer. EXPERIMENTAL DESIGN: This is a multicenter, single-arm, "window of opportunity" pilot study of exemestane (25 mg daily for 21-42 …
2024
observational
2020
Despite mounting evidence that large intramural leiomyomas decrease fecundity during in vitro fertilization cycles, few studies have demonstrated a mechanism for this impact. We hypothesize that large intramural leiomyomas (IM) decrease the…
review
2018
Ovarian cancer is the fifth leading cause of cancer-related deaths in females in the United States. There were an estimated 22,440 new cases and 14,080 deaths due to ovarian cancer in 2017. Most patients present with advanced-stage disease,…
other
2010
OBJECTIVE: We sought to evaluate the expression of G protein-coupled receptor 30 (GPR30) and estrogen receptor (ER)beta in uterine carcinosarcoma (CS). STUDY DESIGN: Immunohistochemistry was performed using antibodies to GPR30, ERbeta, ERa…
case-report
2009
BACKGROUND: Müllerian adenosarcoma is a rare mixed epithelial-mesenchymal tumor. An extragenital site of origin and sarcomatous overgrowth are associated with aggressive clinical behavior. CASE: We present a rare case of extragenital adeno…